Xcout IntelFortrea Holdings Inc.
Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development. The Enabling Services segment, conversely, delivers patient access programs and cutting-edge clinical trial technology solutions, aiming to simplify complex randomization processes and optimize the supply of trial medications for its customers. Fortrea presents a range of engagement options, such as full-service provision, functional service provider (FSP) models, and hybrid structures. Additionally, its portfolio includes managing clinical trials from Phase I through IV, offering distinctive technology-powered trial solutions, and providing post-market approval services. The company's client base primarily consists of pharmaceutical, biotechnology, and medical device entities. Fortrea Holdings Inc. was founded in 2023 and has its headquarters in Durham, North Carolina.
Subscribe to see Fortrea Holdings Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Fortrea Holdings Inc. at a glance
Fortrea Holdings Inc. is a pharmaceuticals company headquartered in Durham, United States. It is publicly listed (FTRE) with a market capitalisation of $2.3B. Xcout tracks 29 named people at Fortrea Holdings Inc., including Anshul Thakral (Chief Executive Officer & Director).
Fortrea Holdings Inc. leadership
- Anshul ThakralChief Executive Officer & Director
- Mark A. MoraisChief Operating Officer & President of Clinical Services
- Drayton VirklerPresident & Chief Commercial Officer
- Leonard Scott DovePresident of Clinical Pharmacology Services
- Mark MoraisChief Operations Officer and President, Clinical Development
- Scott Dove, PhDPresident, Clinical Pharmacology Services
23 more named people on record for Fortrea Holdings Inc., with roles, board committees and tenure — see the full roster →
Fortrea Holdings Inc. competitors
A few of Fortrea Holdings Inc.'s closest competitors — see the full list of competitors and alternatives →
Parexel is a contract research organization (CRO) that provides comprehensive biopharmaceutical services to the life sciences industry. The company offers end-to-end solutions spanning portfolio optimization, regulatory strategy, Phase I-IV clinical trials, market access planning, and post-approval lifecycle management.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Syneos Health is a biopharmaceutical solutions organization and contract research organization (CRO) that provides clinical development, regulatory, safety, and commercialization services. It serves biopharmaceutical and life sciences companies by offering clinical trials, consulting, marketing, and deployment solutions to help bring therapies to market.
Hangzhou Tigermed Consulting Co., Ltd. operates as a contract research organization (CRO) providing clinical trial and research services for pharmaceutical, biotechnology, and medical device companies. The company supports clients throughout the product development lifecycle, offering services such as preclinical development, clinical monitoring, regulatory affairs, data management, and medical device trials.
Circuit Clinical Solutions Inc. operates as an integrated research organization that connects patients, physicians, sponsors, and contract research organizations to facilitate clinical trials. The company provides end-to-end solutions including participant recruitment, trial enrollment, engagement, retention, and backend administrative support to help physicians conduct clinical research within their practices.
Evidenze is a contract research organization (CRO) that provides full-service clinical research, digital health solutions, and pharmacovigilance services. The company serves biotech and small-to-medium pharmaceutical companies by offering study start-up, clinical operations, data management, biostatistics, and medical writing services to accelerate clinical trials and optimize study outcomes.
Get Fortrea Holdings Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Fortrea Holdings Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Fortrea Holdings Inc. in Xcout Intel
- 29 named people with titles, LinkedIn and board committees
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access